Next Article in Journal
Polysaccharides from Marine Bacteria and Their Anti-SARS-CoV-2 Activity
Previous Article in Journal
Azo Dyes and the Microbial World: Synthesis, Breakdown, and Bioactivity
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Evaluation of Antimicrobial Activity of Different Essential Oil Gutta–Percha Solvents Against Enterococcus faecalis and Candida albicans

College of Dentistry, Hawler Medical University, Kurdistan Region, Iraq
Microbiol. Res. 2025, 16(5), 101; https://doi.org/10.3390/microbiolres16050101
Submission received: 29 April 2025 / Revised: 9 May 2025 / Accepted: 16 May 2025 / Published: 19 May 2025

Abstract

:
Essential oils are a common alternative to chloroform for dissolving gutta–percha. This study evaluated the antimicrobial effects of chloroform and six essential oil gutta–percha solvents: eucalyptus oil, orange oil, clove oil, rosemary oil, grapefruit oil, and castor oil, against Enterococcus faecalis and Candida albicans by using disk diffusion techniques. The impregnated sterile disk with 10 μL of pure, tested solvents was inoculated on agar plates at three time contacts: 3 min, 10 min, and 24 h. The mean diameter of the zone of inhibition (ZOI) of each solvent was measured after 24 h of incubation. Against Enterococcus faecalis, in both 3 min and 10 min contact, rosemary oil had the largest ZOI (11.40 ± 0.90 and 11.55 ± 0.68 mm), and orange oil showed the smallest ZOI (7.90 ± 0.31 and 9.05 ± 0.68 mm), respectively. Eucalyptus oil exhibited ZOI with persistence, while grapefruit oil and castor oil showed no ZOI. After 24 h of contact, the largest ZOI was recorded for orange oil. Against Candida albicans, at all three time points, clove oil produced the largest ZOI (20.25 ± 0.82, 23.10 ± 0.93, 30.59 ± 0.74 mm) and chloroform the smallest (10.4 ± 0.77, 9.85 ± 0.62, 11.6 ± 0.65 mm), for 3 min, 10 min, and 24 h, respectively. Conclusively, clove oil, orange oil, and rosemary oil exhibit significant antimicrobial activity like chloroform.

1. Introduction

Root canal treatment (RCT) is a commonly performed dental procedure aimed at saving a tooth that has become infected or is irreversibly damaged [1,2]. However, despite the advancements in techniques and materials, RCT failure remains a significant challenge in clinical practice [3,4]. Failure can occur due to incomplete cleaning of the root canal system, microbial reinfection, or poor sealing of the canal [5,6]. Among the reasons for RCT failure, the persistence of microbial pathogens such as predominant Enterococcus faecalis and Candida albicans within the root canal is a prominent factor [7]. These microorganisms can form biofilms and resist conventional treatments, complicating the healing process [8,9].
E. faecalis, a facultative anaerobe Gram-positive coccus, is frequently identified in secondary endodontic infections (77%) [10]. It is also present, though in smaller quantities (40%), in the bacterial microbiota of primary endodontic infections [3,10,11,12]. This bacterium is found in large quantities both before and after mechanical preparation, indicating its resistance to endodontic procedures [12]. C. albicans, a type of fungus that can switch between yeast and hyphal forms, may become pathogenic under certain circumstances. This transformation can lead to endodontic treatment failure. It is often identified in about 20% of the cases of secondary endodontic infections, especially in situations associated with periradicular lesions and persistent symptoms [13,14].
Gutta–percha (GP) is the most widely used material for root canal obturation due to its biocompatibility, ease of handling, and long-term stability [15]. However, in some cases, retreatment is necessary. The endodontic retreatment procedure includes the removal of the existing obturation GP material by using organic solvents and retreatment rotary instruments and disinfecting the root canal to eliminate any remaining contaminated tissue, bacteria, or fungi responsible for the endodontic failure before restoring the canals once more [16,17].
Various solvents are used to dissolve GP during root canal retreatment [18,19]. Chloroform has traditionally been one of the most effective solvents for GP due to its ability to quickly dissolve the material [20,21]. Chloroform is a volatile organic compound, and prolonged exposure may lead to significant health risks, including liver damage and carcinogenicity [22,23]. Due to these health risks, many dental professionals have searched for safer alternatives, such as essential oil-based solvents. Essential oils are composed of volatile compounds and are biosynthesized by plants. In recent years, essential oils have been widely used in the field of medicine and dentistry due to their effectiveness, non-toxicity, biocompatibility, antimicrobial properties, and non-carcinogenic nature. Several of these oils have been used as effective gutta–percha solvents and alternatives to chloroform in root canal treatments [3,20,24,25].
According to the previous literature, the following essential oils were reported as effective GP solvents: eucalyptus oil [26], orange oil [27], clove oil [28], rosemary oil [29], grapefruit oil [30], and castor oil [31]. However, the antibacterial properties of most of these essential oils, GP solvents, which help to disinfect surfaces while dissolving GP, were not evaluated. This study aims to evaluate the antimicrobial properties of the aforementioned six essential oils and chloroform, specifically against the persistent endodontic pathogens E. faecalis and C. albicans, and identify those that are most effective in reducing the microbial count while facilitating gutta–percha removal.

2. Materials and Methods

2.1. Microorganisms

The microorganisms used in this study, E. faecalis (ATCC 29212) and C. albicans (ATCC-10231), were provided by the pathology laboratory, Medya Diagnostic Center.

2.2. Tested Gutta–Percha Solvents

Seven GP solvents were chosen to assess their antibacterial activity against E. faecalis and antifungal activity against C. albicans. They were chloroform (99%) (Scharlau, Sentmenat, Spain), eucalyptus oil (99%) (Clinix, Tremblay-en-France, France), orange oil (100%) (MIAROMA, Nuneaton, England, UK), clove oil (100%) (MIAROMA, Nuneaton, England, UK), rosemary oil (100%) (MIAROMA, Nuneaton, England, UK), grapefruit oil (100%) (MIAROMA, Nuneaton, England, UK), and castor oil (100%) (MIAROMA, Nuneaton, England, UK).

2.3. Antimicrobial Effectiveness of Solvents Through Disk Diffusion Method

Each E. faecalis and C. albicans strain was reactivated by transferring it into Thioglycolate broth and incubating at 37 °C for 24 h. After 18 h of culturing at 37 °C, the inoculum was adjusted to the 0.5 McFarland standard (1.5 × 108 CFU/mL). The suspension was then evenly spread over Mueller–Hinton agar plates with 500 μL [32]. Sterile, empty disks (6 mm in diameter) were soaked with 10 μL of pure GP solvents. The antimicrobial activities of selected solvents were evaluated at three time intervals: 3 min, 10 min, and 24 h. For the 3 min and 10 min intervals, the impregnated disks were placed on the agar for 3 min and 10 min, respectively, before being removed. At 24 h intervals, the impregnated disks with gutta–percha solvents were left on the inoculated agar. Then, all plates were incubated at 37 °C for 24 h. After overnight incubation, the diameters of the inhibition zones were measured using a millimeter ruler with an accuracy of 0.5 mm [14].

2.4. Statistical Analysis

The data were assessed for normality using both the Shapiro–Wilk and Kolmogorov–Smirnov tests. The inhibition zones were calculated as the mean and standard deviation for all studied GP solvents at three time intervals. The data were analyzed using one-way ANOVA and the Kruskal–Wallis test to compare all groups. Tukey post hoc test and Mann–Whitney U-test were used for pairwise comparisons, using SPSS version 27 (IBM Corp., Armonk, NY, USA). The significance level was set at p < 0.05.

3. Results

3.1. Antibacterial Properties of GP Solvents Against E. faecalis

The ZOI was measured for all seven GP solvents against E. faecalis. At both 3 min and 10 min intervals, there were statistically significant differences in the ZOI among the study solvents, as determined by the Kruskal–Wallis test (p < 0.001) and ANOVA (p < 0.001), respectively. In both time frames, rosemary oil had the largest ZOI, with means of (11.40 ± 0.90 mm) and (11.55 ± 0.68 mm), respectively. However, at the 3 min mark, the ZOI was observed with persistence. On the other hand, the smallest ZOI was recorded for orange oil, with means of (7.90 ± 0.31 mm) at 3 min and (9.05 ± 0.68 mm) at 10 min. At the 24 h mark, the results showed that orange oil produced the largest ZOI with a mean of (15 ± 0.47 mm), and grapefruit oil (7.6 ± 0.31 mm) produced the smallest ZOI. Castor oil recorded no inhibition zone and was excluded from statistical analysis. The differences in ZOI between the solvents were statistically significant, as confirmed by the Kruskal–Wallis test (p < 0.001) (Table 1, Figure 1 and Figure 2).
At the 3 min mark, the Mann–Whitney U-test showed a significant difference between all solvent groups (p < 0.05), except for the comparisons between chloroform and both clove oil and rosemary oil, as well as between eucalyptus oil and both orange oil and clove oil. However, at the 10 min mark, post hoc intergroup analysis showed no significant differences between chloroform, eucalyptus oil, and clove oil (p > 0.05). At the 24 h mark, Mann–Whitney comparisons also revealed significant differences between all groups (p < 0.05), except for the comparison between chloroform and both eucalyptus oil and rosemary oil, as well as between clove oil and both orange oil and rosemary oil), and the comparison between eucalyptus oil and grapefruit (Table 2).
Mann–Whitney U-test and post hoc multiple comparisons were also used to compare the study solvents across different time intervals: 3 min, 10 min, and 24 h. Significant differences were observed between all three time points for all solvents (p < 0.05), except for a non-significant difference found between 3 min and 10 min intervals for chloroform, clove oil, and rosemary oil (p = 0.437, p = 0.124, and p = 0.883, respectively), as well as between the 3 min and 24 h intervals for chloroform (p = 0.343) (Table 3).

3.2. Antifungal Properties of GP Solvents Against C. albicans

Kruskal–Wallis statistical analysis revealed a significant difference in the effectiveness of GP solvents tested against C. albicans at three tested time intervals (p < 0.001). At all three time points, clove oil produced the largest average ZOI diameters (20.25 ± 0.82, 23.10 ± 0.93, 30.59 ± 0.74 mm), followed by orange oil (14.55 ± 0.36, 14 ± 1.24, 24 ± 0.81 mm) for 3 min, 10 min, and 24 h, respectively. The smallest ZOI averages were observed with chloroform (10.4 ± 0.77, 9.85 ± 0.62, 11.6 ± 0.65 mm) at the same intervals. Persistence was noted in both grapefruit oil at 3 min and 10 min and in eucalyptus oil at only 3 min. Castor oil showed no inhibition zone and was excluded from the statistical analysis (Table 4, Figure 3).
Mann–Whitney U-test intergroup comparisons revealed significant differences between all solvent groups (p < 0.05), with a few exceptions. No significant differences were found between grapefruit oil and both chloroform and eucalyptus oil at all three points (p > 0.05). Additionally, no significant differences were observed between rosemary oil and eucalyptus oil and between clove oil and orange oil at all three points. A non-significant difference was also found between rosemary oil with both orange oil at 3 min and 10 min, grapefruit oil at 3 min and 24 h, and eucalyptus oil with orange oil at 10 min and 24 h (Table 5).
A statistical analysis of the three time intervals showed significant differences for all solvents when comparing 24 h with both 10 min and 3 min (p < 0.05). However, when comparing 3 min to 10 min, significant differences were observed only for clove oil (p = 0.011) and grapefruit oil (p = 0.016) (Table 6).

4. Discussion

Solvents are solutions used in endodontic retreatment to soften the GP root-filling material. Various types of GP solvents have been used, including chloroform, xylene, halothane, trichloroethane, and tetrachloroethylene [28,31,33]. However, none of these solvents fulfills all the criteria of an ideal solvent, which should be nontoxic and non-carcinogenic to surrounding tissues, the patient, and clinicians; should effectively soften GP; and should exhibit antibacterial properties [3,18,34,35].
As a promising alternative to synthetic GP solvents, several essential oils have been reported as effective GP solvents, including eucalyptus oil, orange oil, clove oil, rosemary oil, grapefruit oil, and castor oil [3,28,33]. A few studies [3,36] have explored the antibacterial properties of GP solvents against E. faecalis, while only one study [14] compared their antifungal activity against C. albicans. However, none of these studies assessed the antimicrobial activities of various GP solvents or examined their effectiveness over different time intervals.
This study compared the antimicrobial activities of seven GP solvents: chloroform, eucalyptus oil, orange oil, clove oil, rosemary oil, grapefruit oil, and castor oil. For the first time, the antimicrobial properties of four of these essential oils—GP solvents, clove oil, rosemary oil, grapefruit oil, and castor oil—were compared with the more efficient and commonly used solvent chloroform [28,29,36]. Unlike previous studies [3,14,36,37], which measured the activities after 24 h, this study took into account the actual clinical scenario by assessing their antimicrobial effects at time intervals of 3 min, 10 min, and 24 h based on the data collected, which indicated that the time needed for retreatment ranged from 1.5 to 10.8 min [38]. GP solvents typically remain in the canals for 3 to 10 min to soften the obturating GP before removal [18,31,39]. In this study, the effectiveness of a 24 h interval of GP solvents was also assessed for comparison to previous studies, particularly in terms of its impact when contact is sustained over a long period.
The results obtained were classified into four groups. Group 1 (ZOI with no persistence) included chloroform, orange oil, and clove oil for E. faecalis and chloroform, orange oil, clove oil, and rosemary oil for C. albicans. The results align with the findings of Maria et al. (2021), who observed that orange oil had a significantly greater ZOI than chloroform at the 24 h mark [3]. These results suggest that each solvent produced the largest ZOI at a specific time interval. This is consistent with Chouhan et al. (2017), who emphasized that the antibacterial effectiveness of essential oils is influenced by several factors, such as their chemical composition, concentration, and interaction with bacterial cell membranes over time [40].
In contrast, when evaluating the GP solvents against C. albicans, the results showed greater consistency. The ZOI ranked from highest to lowest as follows: clove oil, orange oil, rosemary oil, and chloroform at all three time intervals. Clove oil was significantly more effective against C. albicans. This could be attributed to eugenol, the most abundant ingredient in clove oil, which is recognized as one of the key active ingredients in essential oils effective against C. albicans, while chloroform was considerably less effective among the other three GP solvents at all three time intervals. These results are somewhat consistent with Dutta et al. (2023), who demonstrated that chloroform exhibited lower antifungal activity compared to eucalyptus oil, xylene, and turpentine oil and showed similar antifungal activity to orange oil [14] while increasing the ZOI for all GP solvents against C. albicans over time, most probably related to stability and sustained release of active components, and their antifungal mechanisms of action include different cellular targets. For example, the chemical stability of essential oil components, such as eugenol in clove oil and terpene derivatives in rosemary oil, enables them to continue releasing their antifungal effects even after initial exposure and inhibits the hyphae formation of Candida species. This sustained release contributes to prolonged antifungal activity against C. albicans [41,42].
Group 2 (ZOI with persistence) included oil and rosemary oil for E. faecalis and eucalyptus oil and grapefruit oil for C. albicans. Rosemary oil demonstrated persistence at the 3 min time point only against E. faecalis, while eucalyptus oil exhibited ZOI with persistence at both 3 min and 10 min time intervals against E. faecalis and only at 3 min against C. albicans. The persistence of E. faecalis and C. albicans to some essential oils at short contact times (such as 3 min or 10 min) can be attributed to several factors related to the chemical composition and mode of action of essential oils, as well as the inherent properties of the microorganisms [43]. For example, the major constituent of eucalyptus oil is oxygenated monoterpenes (1,8-cineole) (87.32%) and monoterpenes hydrocarbons (12.45%). Most of its strong antimicrobial activity is due to the presence of 1,8-cineole [3,44,45]. Rosemary essential oil is primarily composed of monoterpenes and their derivatives, making up 95–98% of its content, with the remaining 2–5% consisting of sesquiterpenes [46,47,48]. Essential oils with higher levels of monoterpenes may act more slowly, whereas those with phenolic compounds may have faster action [40]. Although eucalyptus oil and rosemary oil possess potent antimicrobial properties [3,45,47,48], their antimicrobial activities may take more time to become highly effective. The efficacy of essential oils can be dependent on concentration and exposure time. At shorter contact times, the concentration of these active compounds may not reach levels high enough to induce cell membrane disruption, inhibition of enzyme activity, or other cellular damage, allowing the bacteria to adapt and resist the effects. It has been reported that compounds with slow action require 30–60 min to exhibit effective antimicrobial activity [49]. In addition, both E. faecalis and C. albicans have relatively robust cell walls and membranes that can limit the uptake of essential oils. E. faecalis, a Gram-positive bacterium, has a thick peptidoglycan layer that can act as a barrier to many antimicrobial agents [50,51]. In addition, E. faecalis is known to harbor various resistance mechanisms, such as efflux pumps and changes in membrane permeability [52,53], which can decrease susceptibility to essential oils. These resistance mechanisms may be activated or more pronounced at shorter contact times. Similarly, C. albicans has a complex cell wall that includes polysaccharides, like glucan [54], which can reduce the effectiveness of antimicrobial agents during brief exposure. Moreover, brief contact may allow these organisms to repair any damage or activate resistance mechanisms [55].
Group 3 (ZOI only at specific time intervals) included grapefruit oil at the 24 h mark for E. faecalis. Grapefruit oil did not produce any ZOI against E. faecalis at the 3 min and 10 min intervals, while ZOI of 7.6 ± 0.31 was observed against E. faecalis at the 24 h interval, which was significantly lower than all the other tested GP solvents, except for castor oil, which showed no ZOI. Grapefruit oil primarily consists of limonene (88.6–91.5%), β-pinene (0.8–1.2%), linalool (1.1–0.7%), and α-terpinene (0.7–1.0%) [56]. This means that over 96% of grapefruit oil is made up of monoterpenes [57], which tend to act more slowly and require longer contact times to exhibit noticeable effects, such as a ZOI [40].
Group 4 (no ZOI) included castor oil for both E. faecalis and C. albicans. Castor oil did not produce ZOI at any time intervals tested for both E. faecalis and C. albicans. Castor oil is a type of vegetable oil extracted from the seeds of the castor plant (Ricinus communis Linn). The primary fatty acid components in castor oil include ricinoleic acid (92%), oleic acid (3.53%), linoleic acid (2.90%), stearic acid (1.02%), and myristic acid (0.55%). The castor oil derivatives, K-soap, free fatty acids, and methyl esters are responsible for their antibacterial activity, especially against Escherichia coli and Staphylococcus aureus bacteria [58]. Some studies [59,60,61] have shown that castor oil exhibits antimicrobial properties against various bacterial and fungal species. However, its activity against E. faecalis and C. albicans specifically is not always significant. Salles et al. (2015) concluded that castor oil had a non-significant action on E. faecalis but could reduce colony counts for other microorganisms like C. albicans and Staphylococcus aureus [60]. Momoh et al. (2012) showed that fungi were less susceptible to the castor oil extract than bacteria [59]. Alezzi et al. (2022) indicated in their review that castor oil could reduce but not eliminate the colony count of E. faecalis and C. albicans in comparison to the significant antimicrobial activity of NaOCl and chlorhexidine [61]. These might indicate that although castor oil may have a mild inhibitory effect on certain microorganisms, it may fail to produce ZOI in some laboratory studies. The antimicrobial properties of castor oil can vary based on factors such as concentration, the study design, the methodology used, and specific strains of microorganisms tested.
The current study also compared the impact of the duration of application of the tested GP solvents on E. faecalis and C. albicans. For orange oil, clove oil, and rosemary oil, the ZOI increased as the duration of application lengthened, with the highest ZOI observed at 24 h, followed by 10 min and 3 min, respectively. In contrast, the order was different for chloroform and eucalyptus oil. Chloroform exhibited the highest ZOI at 24 h (10.85), followed by 3 min (10.45) and 10 min (10.1). For eucalyptus oil, ZOI was the highest at 10 min (10.5), followed by 3 min (8.95) and 24 h (8.05). However, both the 10 min and 3 min applications showed a higher ZOI than the 24 h application, which was associated with persistence. These results, in agreement with Chouhan et al. (2017), indicated that the antibacterial activity of essential oils can change according to the duration of their application [40]. The time factor is crucial because the longer the essential oil is in contact with the bacteria, the more likely it is that its bioactive compounds (such as terpenes, aldehydes, limonene, phenols, and eugenol) will penetrate the bacterial cell membranes and exert their antimicrobial effects. With short contact times, there may not be enough time for these compounds to have a significant effect [40,43,62,63] and be associated with persistence. The duration of application can influence the bacteria’s growth phase. Essential oils may be more effective during specific phases of bacterial growth (such as the exponential growth phase) and less effective if the bacteria are in a dormant state [64].

5. Conclusions

The findings suggest that essential oils such as clove oil, orange oil, and rosemary oil exhibit significant antimicrobial activity similar to chloroform against both E. faecalis and C. albicans, even with a brief 3 min application, but without the adverse effects of chloroform. As the duration of application increases, the ZOI for most of the tested essential oils significantly increases, while eucalyptus oil shows ZOI with persistence against both E. faecalis and C. albicans at short application of 3 min, whereas grapefruit oil demonstrates antibacterial effects against E. faecalis only after a prolonged 24 h exposure. In contrast, castor oil does not exhibit any antimicrobial activity against E. faecalis or C. albicans at any tested duration.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

All data were put it in the manuscript.

Conflicts of Interest

The author declares no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
ZOIZone of inhibition
RCTRoot canal treatment
E. faecalisEnterococcus faecalis
C. albicansCandida albicans

References

  1. El-Ma’aita, A.M.; Qualtrough, A.J.; Darcey, J.; Hunter, M.J. Rethinking root canal treatment: Understanding the difference between preventing and treating endodontic infection. Br. Dent. J. 2015, 219, 13–16. [Google Scholar] [CrossRef] [PubMed]
  2. Nepal, M.; Shubham, S.; Tripathi, R.; Khadka, J.; Shrestha, K. Indications of Root Canal Treatment for Patients Visiting Tertiary Care Hospital: A Hospital Based Prospective Study. J. Univ. Coll. Med. Sci. 2023, 11, 45–49. [Google Scholar] [CrossRef]
  3. Maria, R.; Dutta, S.D.; Thete, S.G.; Al Attas, M.H. Evaluation of antibacterial properties of organic gutta-percha solvents and synthetic solvents against Enterococcus faecalis. J. Int. Soc. Prev. Community Dent. 2021, 11, 179–183. [Google Scholar] [CrossRef]
  4. Drukteinis, S.; Rajasekharan, S.; Widbiller, M. Advanced Materials for Clinical Endodontic Applications: Current Status and Future Directions. J. Funct. Biomater. 2024, 15, 31. [Google Scholar] [CrossRef]
  5. Gulabivala, K.; Ng, Y.L. Factors that affect the outcomes of root canal treatment and retreatment—A reframing of the principles. Int. Endod. J. 2023, 56, 82–115. [Google Scholar] [CrossRef]
  6. Jang, Y.E.; Kim, Y.; Kim, S.Y.; Kim, B.S. Predicting early endodontic treatment failure following primary canal treatment. BMC Oral Health 2024, 24, 327. [Google Scholar] [CrossRef]
  7. Ahmed, S.; Hassan, S.J.; Gajdhar, S.; Alhazmi, L.S.; Khalifah, R.Y.; Alrifai, J.A.; Aljhdali, S.S.; Maqbul, M.S. Prevalence of Enterococcus faecalis and Candida albicans in endodontic retreatment Cases: A comprehensive study. Saudi Dent. J. 2024, 36, 539–545. [Google Scholar] [CrossRef]
  8. Méndez-González, V.; Casillas-Contreras, C.; Vitales-Noyola, M.; Alvarado-Hernández, D.; González-Amaro, A.; Aragón-Piña, A.; Pozos-Guillén, A. Elimination of E. faecalis and C. albicans Biofilm: A comparison between single and multiple file systems in an Ex Vivo study. Odovtos Int. J. Dent. Sci. 2023, 25, 53–64. [Google Scholar] [CrossRef]
  9. Wu, B.; Zhou, Z.; Hong, X.; Xu, Z.; Xu, Y.; He, Y.; Chen, S. Novel approaches on root canal disinfection methods against E. faecalis. J. Oral Microbiol. 2025, 17, 2475947. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  10. Stuart, C.H.; Schwartz, S.A.; Beeson, T.J.; Owatz, C.B. Enterococcus faecalis: Its role in root canal treatment failure and current concepts in retreatment. J. Endod. 2006, 32, 93–98. [Google Scholar] [CrossRef]
  11. Williams, J.; Trope, M.; Caplan, D.; Shugars, D. Detection and quantitation of E. faecalis by real-time PCR (qPCR), reverse transcription-PCR (RT-PCR), and cultivation during endodontic treatment. J. Endod. 2006, 32, 715–721. [Google Scholar] [CrossRef] [PubMed]
  12. Barbosa-Ribeiro, M.; De-Jesus-Soares, A.; Zaia, A.; Ferraz, C.; Almeida, J.; Gomes, B. Quantification of Lipoteichoic Acid Contents and Cultivable Bacteria at the Different Phases of the Endodontic Retreatment. J. Endod. 2016, 42, 552–556. [Google Scholar] [CrossRef] [PubMed]
  13. Molander, A.; Reit, C.; Dahlen, G.; Kvist, T. Microbiological status of root-filled teeth with apical periodontitis. Int. Endod. J. 1998, 31, 1–7. [Google Scholar] [CrossRef]
  14. Dutta, S.D. Determination of antifungal effect of natural oil and synthetic gutta percha solvents against Candida albicans: A disc diffusion assay. J. Pharm. Bioallied Sci. 2023, 15, S235–S238. [Google Scholar] [CrossRef]
  15. Vishwanath, V.; Rao, H.M. Gutta-percha in endodontics—A comprehensive review of material science. J. Conserv. Dent. 2019, 22, 216–222. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  16. Koçak, M.M.; Koçak, S.; Türker, S.A.; Sağlam, B.C. Cleaning efficacy of reciprocal and rotary systems in the removal of root canal filling material. J. Conserv. Dent. 2016, 19, 184–188. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  17. Alves, F.R.F.; Rôças, I.N.; Provenzano, J.C.; Siqueira, J.F., Jr. Removal of the Previous Root Canal Filling Material for Retreatment: Implications and Techniques. Appl. Sci. 2022, 12, 10217. [Google Scholar] [CrossRef]
  18. Dotto, L.; Sarkis-Onofre, R.; Bacchi, A.; Pereira, G.K.R. The use of solvents for gutta-percha dissolution/removal during endodontic retreatments: A scoping review. J. Biomed. Mater. Res. B Appl. Biomater. 2021, 109, 890–901. [Google Scholar] [CrossRef] [PubMed]
  19. Goka, R.Y.; Nyako, E.A.; Ampofo, P.C.; Hewlett, S.A.; Acheampong, A.O.; Ndanu, T.A.; Konadu, A.B.; Ankoh, S.E.; Adu-Ampomah, N.F. A comparative study of the softening abilities of three gutta-percha solvents used during endodontic retreatment. HSI J. 2024, 6, 969–976. [Google Scholar]
  20. Poggio, C.; Dagna, A.; Mirando, M.; Beltrami, R.; Chiesa, M.; Colombo, M. Gutta-Percha Solvents Alternative to Chloroform: An In Vitro Comparative Evaluation. EC Dent. Sci. 2017, 15, 51–56. [Google Scholar]
  21. Aishuwariya, T.; Sindhu, R. An Update on Gutta-Percha Retrieval Methods. Int. J. Dent. Oral Sci. 2021, 8, 1651–1654. [Google Scholar] [CrossRef]
  22. Verma, P.; Nosrat, A.; Tordik, P. Hazards of Improper Dispensary: Literature Review and Report of an Accidental Chloroform Injection. J. Endod. 2018, 44, 1042–1047. [Google Scholar] [CrossRef] [PubMed]
  23. Alamoudi, R.A. Comparative evaluation of the efficacy of different solvents on the removal of endodontic bioceramic sealers: An in vitro study. J. Int. Clin. Dent. Res. Organ. 2024, 16, 126–134. [Google Scholar] [CrossRef]
  24. Ferreira, I.; Grenho, L.; Gomes, P.; Braga, A.C.; Fernandes, M.H.; Lopes, M.A.; Pina-Vaz, I. Efficacy and Cytotoxicity of Binary Mixtures as Root Canal Filling Solvents. Materials 2020, 13, 3237. [Google Scholar] [CrossRef]
  25. Ferreira, I.; Pina-Vaz, I. The Novel Role of Solvents in Non-Surgical Endodontic Retreatment. Appl. Sci. 2022, 12, 5492. [Google Scholar] [CrossRef]
  26. Khabadze, Z.S.; Nazarova, D.A.; Ismailov, F.R.; Kotelnikova, A.P.; Shilyaeva, E.S. Using solvents for dissolving guttapercha: A systematic review. Endod. Today 2022, 20, 42–46. [Google Scholar]
  27. Kothiwan, P.P.; Patil, G.V.; Patel, A.; Paul, P.; Reche, A. Efficacy of Orange Oil, Lemon Oil and Xylene as Solvents in Removing Gutta Percha from Curved Root Canals: An In-vitro Study. J. Clin. Diagn. Res. Dr. 2022, 16, ZK01–ZK03. [Google Scholar] [CrossRef]
  28. Kulkarni, G.; Podar, R.; Singh, S.; Dadu, S.; Purba, R.; Babel, S. Comparative evaluation of dissolution of a new resin-coated Gutta-percha, by three naturally available solvents. Endodontology 2016, 28, 1437. [Google Scholar]
  29. Deepthi, M.; Ananthakrishna, S.; Pradeep, P.; Muneer, S.; Syam, T. Dissolving efficacy of different endodontic solvents on gutta percha—An in-vitro study. Int. J. Dent. Sci. Innov. Res. 2022, 5, 508–513. [Google Scholar]
  30. Jantarat, J.; Malhotra, W.; Sutimuntanaku, S. Efficacy of grapefruit, tangerine, lime, and lemon oils as solvents for softening guttapercha in root canal retreatment procedures. J. Investig. Clin. Dent. 2013, 4, 60–63. [Google Scholar] [CrossRef]
  31. Daokar, S.G.; Kagne, K.S.; Pawar, K.S.; Wahane, K.D.; Mahakale, C.R.; Thorat, T.V. Comparative Evaluation of Efficacy of Three Natural Oils as Gutta-percha Solvents: In Vitro Study. J. Aesthet. Dent. Conserv. Dent. Endod. 2019, 1, 1–4. [Google Scholar]
  32. Huang, Y.; Li, X.; Mandal, P.; Wu, Y.; Liu, L.; Gui, H.; Liu, J. The in vitro antimicrobial activities four endodontic sealers. BMC Oral Health 2019, 19, 118. [Google Scholar] [CrossRef]
  33. Parvin, C.A.; Hoque, T.; Hasan, M.S.; Rumon, K.; Ayumi, A.H.; Hossain, M. Effectiveness of Chloroform and Orange Oil as Gutta-percha Solvents used in Endodontic Retreatment: An In Vitro Study. Int. J. Adv. Multidiscip. Res. Stud. 2024, 4, 447–451. [Google Scholar] [CrossRef]
  34. Magalhães, B.S.; Johann, J.E.; Lund, R.G.; Martos, J.; Del Pino, F.A. Dissolving efficacy of some organic solvents on gutta-percha. Braz. Oral Res. 2007, 21, 303–307. [Google Scholar] [CrossRef]
  35. Mittal, N.; Jain, J. Spiral computed tomography assessment of the efficacy of different rotary versus hand retreatment system. J. Conserv. Dent. 2014, 17, 8–12. [Google Scholar] [CrossRef]
  36. Subbiya, A.; Padmavathy, K.; Mahalakshmi, K. Evaluation of the antibacterial activity of three gutta-percha solvents against Enterococcus faecalis. Int. J. Artif. Organs. 2013, 36, 358–362. [Google Scholar] [CrossRef] [PubMed]
  37. Edgar, S.W.; Marshall, J.G.; Baumgartner, J.C. The antimicrobial effect of chloroform on Enterococcus faecalis after gutta-percha removal. J. Endod. 2006, 32, 1185–1187. [Google Scholar] [CrossRef]
  38. Opacic-Galić, V.; Adžić, S.M.; Dželetović, B.; Vlajić, T. In vitro study of essential oils efficacy as alternative solvents in endodontic retreatment. Stomatol. Glas. Srb. 2021, 68, 173–180. [Google Scholar] [CrossRef]
  39. Campello, A.F.; Almeida, B.M.; Franzoni, M.A.; Alves, F.R.F.; Marceliano-Alves, M.F.; Rôças, I.N.; Siqueira, J.F., Jr.; Provenzano, J.C. Influence of solvent and a supplementary step with a finishing instrument on filling material removal from canals connected by an isthmus. Int. Endod. J. 2019, 52, 716–724. [Google Scholar] [CrossRef] [PubMed]
  40. Chouhan, S.; Sharma, K.; Guleria, S. Antimicrobial Activity of Some Essential Oils-Present Status Future Perspectives. Medicines 2017, 4, 58. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  41. Santos, A.A.; Oliveira-Filho, A.A.; Teixeira, B.A.; Borchardt, H.; Galvão, J.L.F.M.; Medeiros, M.A.A.; Alves, M.S.; Barbosa, D.H.X.; Mafra, R.P.; Nascimento, Y.M.; et al. Essential oil: A promising antifungal and antibiofilm agent against 19 oral Candida albicans. Braz. J. Biol. 2024, 84, e283646. [Google Scholar] [CrossRef] [PubMed]
  42. Yuan, X.; Cao, D.; Xiang, Y.; Jiang, X.; Liu, J.; Bi, K.; Dong, X.; Wu, T.; Zhang, Y. Antifungal activity of essential oils and their potential synergistic effect with amphotericin B. Sci. Rep. 2024, 14, 31125. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  43. Ozogul, Y.; Kuley, E.; Ucar, Y.; Ozogul, F. Antimicrobial Impacts of Essential Oils on Food Borne-Pathogens. Recent Pat. Food Nutr. Agric. 2015, 7, 53–61. [Google Scholar] [CrossRef] [PubMed]
  44. Tanujaya, C.; Aryadi; Hardini, N. Efficacy of eucalyptus oil (Eucalyptus globulus), sweet orange oil (Citrus sinensis), and grapefruit oil (Citrus paradisi) as bioceramic sealer solvents. Sci. Dent. J. 2020, 4, 120–123. [Google Scholar] [CrossRef]
  45. Shala, A.Y.; Gururani, M.A. Phytochemical properties and diverse beneficial roles of Eucalyptus Globulus Labill: A review. Horticulture 2021, 7, 450. [Google Scholar] [CrossRef]
  46. Szumny, A.; Figiel, A.; Gutiérrez-Ortíz, A.; Carbonell-Barrachina, A. Composition of rosemary essential oil (Rosmarinus officinalis) as affected by drying method. J. Food Eng. 2010, 97, 253–260. [Google Scholar] [CrossRef]
  47. Sienkiewicz, M.; Łysakowska, M.; Pastuszka, M.; Bienias, W.; Kowalczyk, E. The potential of use basil and rosemary essential oils as effective antibacterial agents. Molecules 2013, 18, 9334–9351. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  48. Lešnik, S.; Furlan, V.; Urban, B. “Rosemary (Rosmarinus officinalis L.): Extraction techniques, analytical methods and health-promoting biological effects. Phytochem. Rev. 2021, 20, 1273–1328. [Google Scholar] [CrossRef]
  49. Friedman, M.; Henika, P.R.; Levin, C.E.; Mandrell, R.E. Antibacterial activities of plant essential oils and their components against Escherichia coli O157:H7 and Salmonella enterica in apple juice. J. Agric. Food Chem. 2004, 52, 6042–6048. [Google Scholar] [CrossRef]
  50. Chang, J.D.; Wallace, A.G.; Foster, E.E.; Kim, S.J. Peptidoglycan Compositional Analysis of Enterococcus faecalis Biofilm by Stable Isotope Labeling by Amino Acids in a Bacterial Culture. Biochemistry 2018, 57, 1274–1283. [Google Scholar] [CrossRef]
  51. Karaman, R.; Jubeh, B.; Breijyeh, Z. Resistance of Gram-Positive Bacteria to Current Antibacterial Agents and Overcoming Approaches. Molecules 2020, 25, 2888. [Google Scholar] [CrossRef] [PubMed]
  52. Hollenbeck, B.L.; Rice, L.B. Intrinsic and acquired resistance mechanisms in enterococcus. Virulence 2012, 3, 421–433. [Google Scholar] [CrossRef]
  53. Fahim, N.A.; Masud, R.I.; Salam, S.; Hasan, M.A.; Rahman, A.M.; Punom, S.A.; Rahman, M.T. Role of Enterococcus in spreading antimicrobial resistance genes and its health significance. Ger. J. Vet. Res. 2025, 5, 95–112. [Google Scholar]
  54. Garcia-Rubio, R.; de Oliveira, H.C.; Rivera, J.; Trevijano-Contador, N. The Fungal Cell Wall: Candida, Cryptococcus, and Aspergillus Species. Front. Microbiol. 2020, 10, 2993. [Google Scholar] [CrossRef] [PubMed]
  55. Zhang, F.; Cheng, W. The Mechanism of Bacterial Resistance and Potential Bacteriostatic Strategies. Antibiotics 2022, 11, 1215. [Google Scholar] [CrossRef]
  56. Uysal, B.; Sozmen, F.; Aktas, O.; Oksal, B.S.; Kose, E.O. Essential oil composition and antibacterial activity of the grapefruit (Citrus paradisi. L) peel essential oils obtained by solvent-free microwave extraction: Comparison with hydrodistillation. Int. J. Food Sci. Technol. 2011, 46, 1455–1461. [Google Scholar] [CrossRef]
  57. Deng, W.; Liu, K.; Cao, S.; Sun, J.; Zhong, B.; Chun, J. Chemical Composition, Antimicrobial, Antioxidant, and Antiproliferative Properties of Grapefruit Essential Oil Prepared by Molecular Distillation. Molecules 2020, 25, 217. [Google Scholar] [CrossRef]
  58. Fitranda, M.I.; Sutrisno, S.; Marfu’ah, S. Physicochemical Properties and Antibacterial Activity of Castor Oil and Its Derivatives. IOP Conf. Ser. Mater. Sci. Eng. 2020, 833, 012009. [Google Scholar] [CrossRef]
  59. Momoh, A.O.; Oladunmoye, M.K.; Adebolu, T. Evaluation of the antimicrobial and phytochemical properties of oil from castor seeds (Ricinus communis Linn). Bull. Environ. Pharmacol. Life Sci. 2012, 1, 21–27. [Google Scholar]
  60. Salles, M.M.; Oliveira, V.d.C.; Souza, R.F.; Silva, C.H.; Paranhos, H. Antimicrobial action of sodium hypochlorite and castor oil solutions for denture cleaning—In vitro evaluation. Braz. Oral Res. 2015, 29, 1–6. [Google Scholar] [CrossRef]
  61. Alezzi, M.; Alfreahat, N.; Hussein, R.; Seoudi, N. The Effect of using herbal Extracts as irrigant solution in disinfecting root canals of endodontically treated teeth: A narrative review. Int. J. Dent. Oral Health 2022, 8, 1–12. [Google Scholar] [CrossRef]
  62. Masyita, A.; Mustika Sari, R.; Dwi Astuti, A.; Yasir, B.; Rahma Rumata, N.; Emran, T.B.; Nainu, F.; Simal-Gandara, J. Terpenes and terpenoids as main bioactive compounds of essential oils, their roles in human health and potential application as natural food preservatives. Food Chem. X 2022, 13, 100217. [Google Scholar] [CrossRef] [PubMed]
  63. Khwaza, V.; Aderibigbe, B.A. Antibacterial activity of selected essential oil components and their derivatives: A review. Antibiotics 2025, 14, 68. [Google Scholar] [CrossRef] [PubMed]
  64. Gonzalez, J.M.; Aranda, B. Microbial growth under limiting conditions-future perspectives. Microorganisms 2023, 11, 1641. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
Figure 1. ZOI (mm) in different GP solvents against E. faecalis and C. albicans: (a) ZOI rosemary oil with persistence at 3 min against E. faecalis; (b) ZOI eucalyptus oil with persistence at 10 min against E. faecalis; (c) ZOI of chloroform and essential oil GP solvents at 10 min against C. albicans.
Figure 1. ZOI (mm) in different GP solvents against E. faecalis and C. albicans: (a) ZOI rosemary oil with persistence at 3 min against E. faecalis; (b) ZOI eucalyptus oil with persistence at 10 min against E. faecalis; (c) ZOI of chloroform and essential oil GP solvents at 10 min against C. albicans.
Microbiolres 16 00101 g001
Figure 2. Mean value ZOI (mm) of GP solvents against E. faecalis.
Figure 2. Mean value ZOI (mm) of GP solvents against E. faecalis.
Microbiolres 16 00101 g002
Figure 3. Mean value ZOI (mm) of GP solvents against C. albicans.
Figure 3. Mean value ZOI (mm) of GP solvents against C. albicans.
Microbiolres 16 00101 g003
Table 1. Descriptive statistics ZOI of GP solvents against E. faecalis. * ZOI with persistence (p).
Table 1. Descriptive statistics ZOI of GP solvents against E. faecalis. * ZOI with persistence (p).
GP SolventsTimeNMean (mm)Std. DeviationStd. Error95% Confidence Interval for MeanMinimumMaximum
LowerUpper
Chloroform3 min1010.45±0.760.249.9010.999.5012.00
Eucalyptus oil108.90 * p±0.690.228.399.408.0010.00
Orange oil107.90±0.310.107.678.127.508.50
Clove oil109.45±0.430.139.139.769.0010.00
Rosemary oil1011.40 * p±0.900.2810.7512.0410.0012.50
Grapefruit oil100000000
Castor oil100000000
Chloroform10 min1010.1±0.650.209.6210.579.0011.00
Eucalyptus oil1010.5 * p±1.080.349.7211.279.0012.50
Orange oil109.05±0.680.218.559.548.0010.00
Clove oil1010.2±0.750.239.6610.739.0011.50
Rosemary oil1011.55±0.680.2111.0512.0410.5012.50
Grapefruit oil100000000
Castor oil100000000
Chloroform24 h1010.85±0.410.1310.5511.1410.511.5
Eucalyptus oil108.05±0.550.177.658.447.59.5
Orange oil1015±0.470.1414.6615.331415
Clove oil1014.55±0.550.1714.1514.9413.515.5
Rosemary oil1012.95±0.430.1312.6313.2612.513.5
Grapefruit oil107.6±0.310.17.377.8278
Castor oil100000000
Table 2. Intergroup comparisons of disk diffusion test of GP solvents against E. faecalis. The mean difference is significant at the p < 0.05 level.
Table 2. Intergroup comparisons of disk diffusion test of GP solvents against E. faecalis. The mean difference is significant at the p < 0.05 level.
GP SolventsTimeChloroformEucalyptus OilOrange OilClove OilRosemary OilGrapefruit Oil
Chloroform3 min_0.0060.0000.0710.259_
Eucalyptus oil0.006_0.0770.3340.000_
Orange oil0.0000.077_0.0060.000_
Clove oil0.0710.3340.006_0.003_
Rosemary oil0.2590.0000.0000.003__
Chloroform10 min_0.3310.0030.7750.000_
Eucalyptus oil0.331_0.0020.4800.018_
Orange oil0.0030.002_0.0020.000_
Clove oil0.7750.4800.002_0.000_
Rosemary oil0.0000.0180.0000.000__
Chloroform24 h_0.1150.0000.0040.1910.022
Eucalyptus oil0.115_0.0000.0000.0040.479
Orange oil0.0000.000_0.5160.0260.000
Clove oil0.0040.0000.516_0.1150.000
Rosemary oil0.1910.0040.0260.115_0.000
Grapefruit oil0.0220.4790.0000.0000.000_
Table 3. Intergroup comparisons of disk diffusion test of GP solvents against E. faecalis at three time intervals (3 min, 10 min, and 24 h). The mean difference is significant at the p < 0.05 level.
Table 3. Intergroup comparisons of disk diffusion test of GP solvents against E. faecalis at three time intervals (3 min, 10 min, and 24 h). The mean difference is significant at the p < 0.05 level.
GroupsChloroformEucalyptus OilOrange OilClove OilRosemary Oil
3 min–10 min0.4370.0130.0220.1240.883
3 min–24 h0.3430.0440.0000.0000.000
10 min–24 h0.0330.0000.0070.0020.000
Table 4. Descriptive statistics zone of inhibition of GP solvents against C. albicans. * ZOI with persistence (p).
Table 4. Descriptive statistics zone of inhibition of GP solvents against C. albicans. * ZOI with persistence (p).
GP SolventsTimeMean (mm)Std. DeviationStd. Error95% Confidence Interval for MeanMinimumMaximum
LowerUpper
Chloroform3 min10.40±0.770.249.8410.959.5011.50
Eucalyptus oil12.50 * p±0.700.2211.9913.0011.0013.00
Orange oil14.55±0.360.1114.2814.8114.0015.00
Clove oil20.25±0.820.2619.6520.8419.0021.50
Rosemary oil12.95±0.430.1312.6313.2612.5013.50
Grapefruit oil12.10 * p±0.450.1411.7712.4211.5012.50
Castor oil0000000
Chloroform10 min9.85±0.620.199.4010.299.0011.00
Eucalyptus oil12.25±0.880.2811.6112.8810.5013.50
Orange oil14.00±1.240.3913.1014.8911.0015.00
Clove oil23.10±0.930.2922.4223.7722.0024.50
Rosemary oil12.85±1.130.3512.0413.6510.5014.00
Grapefruit oil10.90 * p±0.450.1410.5711.2210.0011.50
Castor oil0000000
Chloroform24 h11.60±0.650.2011.1212.0710.5012.50
Eucalyptus oil15.50±0.570.1815.0815.9114.5016.50
Orange oil24.00±0.810.2523.4124.5822.5025.50
Clove oil30.59±0.740.2330.0531.1229.5031.50
Rosemary oil15.30±0.420.1314.9915.6014.5016.00
Grapefruit oil14.25±0.420.1313.9414.5513.5014.50
Castor oil0000000
Table 5. Mann–Whitney intergroup comparisons of disk diffusion test of GP solvents against C. albicans.
Table 5. Mann–Whitney intergroup comparisons of disk diffusion test of GP solvents against C. albicans.
GP SolventsTimeChloroformEucalyptus OilOrange OilClove OilRosemary OilGrapefruit Oil
Chloroform3 min_0.0110.0000.0000.0010.104
Eucalyptus oil0.011_0.0110.0000.4950.364
Orange oil0.0000.011_0.1980.0640.001
Clove oil0.0000.0000.198_0.0020.000
Rosemary oil0.0010.4950.0640.002_0.112
Grapefruit oil0.1040.3640.0010.0000.112_
Chloroform10 min-0.0060.0000.0000.0010.195
Eucalyptus oil0.006-0.0820.0000.5040.142
Orange oil0.0000.082-0.0810.2840.001
Clove oil0.0000.0000.081-0.0050.000
Rosemary oil0.0010.5040.2840.005-0.033
Grapefruit oil0.1950.1420.0010.0000.033-
Chloroform24 h-0.0010.0000.0000.0020.169
Eucalyptus oil0.001-0.0660.0020.7870.054
Orange oil0.0000.066-0.1990.0350.000
Clove oil0.0000.0020.199-0.0010.000
Rosemary oil0.0020.7870.0350.001-0.097
Grapefruit oil0.1690.0540.0000.0000.097-
Table 6. Intergroup comparisons of disk diffusion test of GP solvents against C. albicans at three time intervals (3 min, 10 min, and 24 h).
Table 6. Intergroup comparisons of disk diffusion test of GP solvents against C. albicans at three time intervals (3 min, 10 min, and 24 h).
GroupsChloroformEucalyptus OilOrange OilClove OilRosemary OilGrapefruit Oil
3 min–10 min0.1940.6250.6060.0110.9510.016
3 min–24 h0.0020.0000.0000.0000.0000.008
10 min–24 h0.0000.0000.0000.0110.0000.000
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Saeed, M. Evaluation of Antimicrobial Activity of Different Essential Oil Gutta–Percha Solvents Against Enterococcus faecalis and Candida albicans. Microbiol. Res. 2025, 16, 101. https://doi.org/10.3390/microbiolres16050101

AMA Style

Saeed M. Evaluation of Antimicrobial Activity of Different Essential Oil Gutta–Percha Solvents Against Enterococcus faecalis and Candida albicans. Microbiology Research. 2025; 16(5):101. https://doi.org/10.3390/microbiolres16050101

Chicago/Turabian Style

Saeed, Media. 2025. "Evaluation of Antimicrobial Activity of Different Essential Oil Gutta–Percha Solvents Against Enterococcus faecalis and Candida albicans" Microbiology Research 16, no. 5: 101. https://doi.org/10.3390/microbiolres16050101

APA Style

Saeed, M. (2025). Evaluation of Antimicrobial Activity of Different Essential Oil Gutta–Percha Solvents Against Enterococcus faecalis and Candida albicans. Microbiology Research, 16(5), 101. https://doi.org/10.3390/microbiolres16050101

Article Metrics

Back to TopTop